On May 14, the following stocks were determined to be overbought: Ardea Biosciences, Inc, Vertex Pharmaceuticals Incorporated, and Gen-Probe Inc. The demand for these stocks have pushed the prices of the underlying assets to levels that do not support the fundamentals. This is interpreted as a sign that the stocks are overvalued and may experience a pullback.
Shares of Ardea Biosciences, Inc (RDEA) fell by 0.06% or $-0.02/share to $31.72. In the past year, the shares have traded as low as $13.15 and as high as $31.89. On average, 977690 shares of RDEA exchange hands on a given day and today's volume is recorded at 49080.
Shares of Vertex Pharmaceuticals Incorporated (VRTX) traded higher by 3.23% or $2.00/share to $64.03. In the past year, the shares have traded as low as $26.50 and as high as $64.51. On average, 3315170 shares of VRTX exchange hands on a given day and today's volume is recorded at 2854360.
Shares of Gen-Probe Inc (GPRO) fell by 0.07% or $-0.06/share to $81.25. In the past year, the shares have traded as low as $53.92 and as high as $86.96. On average, 800440 shares of GPRO exchange hands on a given day and today's volume is recorded at 286081.
